Minivelle

Role

Indications

Reactions

Primary

Product Used For Unknown Indication	52.5%
Hot Flush	29.5%
Menopausal Symptoms	5.2%
Hormone Replacement Therapy	3.6%
Menopause	2.1%
Night Sweats	1.3%
Vulvovaginal Dryness	1.1%
Hysterectomy	0.9%
Hypothyroidism	0.5%
Insomnia	0.5%
Back Pain	0.4%
Fluid Retention	0.4%
Hypertension	0.4%
In Vitro Fertilisation	0.4%
Migraine	0.4%
Thyroid Disorder	0.4%
Affective Disorder	0.2%
Alcoholism	0.2%
Appetite Disorder	0.2%
Artificial Menopause	0.2%

Oestradiol Decreased	27.6%
Product Quality Issue	15.2%
Wrong Technique In Drug Usage Process	13.4%
Hot Flush	11.4%
Drug Ineffective	6.6%
Off Label Use	5.8%
Metrorrhagia	3.8%
Vaginal Haemorrhage	2.8%
Application Site Irritation	2.3%
Application Site Rash	1.3%
Night Sweats	1.3%
Rash	1.3%
Weight Increased	1.3%
Headache	1.0%
Nausea	1.0%
Pain In Extremity	1.0%
Feeling Abnormal	0.8%
Menstrual Disorder	0.8%
Mood Swings	0.8%
Muscle Spasms	0.8%

Secondary

Hot Flush	36.9%
Product Used For Unknown Indication	22.5%
Hormone Replacement Therapy	6.3%
Menopausal Symptoms	5.4%
Night Sweats	5.4%
Menopause	4.5%
Insomnia	2.7%
Vulvovaginal Dryness	2.7%
Dyspepsia	1.8%
Feeling Abnormal	1.8%
Hypothyroidism	1.8%
Affective Disorder	0.9%
Alcoholism	0.9%
Appetite Disorder	0.9%
Artificial Menopause	0.9%
Bladder Disorder	0.9%
Bone Loss	0.9%
Depression	0.9%
Fatigue	0.9%
Fluid Retention	0.9%

Wrong Technique In Drug Usage Process	25.5%
Hot Flush	14.5%
Product Quality Issue	12.7%
Weight Increased	7.3%
Application Site Rash	5.5%
Off Label Use	5.5%
Nausea	3.6%
Panic Reaction	3.6%
Application Site Irritation	1.8%
Breast Tenderness	1.8%
Drug Dose Omission	1.8%
Inappropriate Schedule Of Drug Administration	1.8%
Insomnia	1.8%
Lethargy	1.8%
Menorrhagia	1.8%
Menstrual Disorder	1.8%
No Adverse Event	1.8%
Oestradiol Increased	1.8%
Palpitations	1.8%
Peripheral Coldness	1.8%

Concomitant

Product Used For Unknown Indication	85.7%
Multiple Sclerosis	9.5%
Endometriosis	4.8%